Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
MaxCyte ( (MXCT) ) has provided an announcement.
MaxCyte, Inc., a non-UK issuer, has announced a change in its major holdings, with BlackRock, Inc. acquiring or disposing of voting rights, resulting in a total of 7.63% voting rights held in MaxCyte. This adjustment in BlackRock’s holdings reflects a slight decrease from a previous position of 7.71%, indicating a minor shift in the company’s shareholder structure.
More about MaxCyte
YTD Price Performance: -25.00%
Average Trading Volume: 40,604
Technical Sentiment Signal: Strong Buy
Current Market Cap: £253.6M
Find detailed analytics on MXCT stock on TipRanks’ Stock Analysis page.